New York City—June 14, 2010
Anne Mulcahy has been with Xerox for more than three decades, serving as an inspiration and role model by working her way from sales representative to the most senior role in the company. Under her leadership, Xerox has become the world leader in business process and document management.
Since stepping down from Xerox in May, Mulcahy became chair of the Board of Trustees of Save the Children, a global humanitarian organization that aids children living in poverty. She will draw upon her 33 years of innovative leadership at Xerox to guide Save the Children through a critical period in which the needs of children living in poverty are increasing. Mulcahy says she was inspired by the humanitarian organization’s long history, fiscal accountability and ability to improve the lives of children at a global level.
“It is with great pride that we honor Anne Mulcahy, an extraordinary leader and humanitarian committed to the health and well being of children in need around the world and in the United States,” said Louis A. Shapiro, president and chief executive officer of Hospital for Special Surgery. “The efforts of leaders like Anne serve as a model for those of us in the healthcare business working for the greater social good.”
In addition to serving as a philanthropic leader, Mulcahy has been recognized repeatedly as one of the country’s most influential female leaders. In 2005, Mulcahy was named one of 50 women to watch by The Wall Street Journal. That same year, she was ranked as one of the most powerful women in America by Forbes Magazine.
Mulcahy earned her bachelor’s degree in English and journalism from Marymount College in Tarrytown, N.Y. She joined Xerox as a sale representative in 1976 and by 1992 was elected vice president of human resources. Mulcahy went on to become chief staff officer and corporate senior vice president. In 2001, she was chosen by the Board of Directors to serve as CEO. Although she recently retired from the Board of Directors of Xerox, Mulcahy still serves on the boards of Catalyst, Johnson & Johnson, Target and The Washington Post Companies.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.